Skip to main content

InforSense, Genomatix, Spotfire, Genedata, Ingenuity, Molecular Connections, Eidogen-Sertanty

Premium

Windber Extends InforSense Collaboration

Windber Research Institute has extended its collaboration with InforSense, InforSense said this week.

The partnership, in which InforSense will help Windber in developing an informatics platform for translational medicine research, began last May [BioInform 05-09-05].

Windber is now using a range of InforSense technologies in the collaboration, including the InforSense KDE analytical platform, InforSense's In-Oracle Environment for accessing Oracle data through the workflow interface, the TextSense literature analysis add-on, and the BioSense bioinformatics add-on.

InforSense also developed a customized data warehouse for integrating clinical and experimental data, and a web interface that allows clinicians to select patient and associated information for further analysis of treatment options.

Financial terms of the agreement were not disclosed.


Research Instruments to Distribute Genomatix Software in Singapore, Malaysia, Thailand

Genomatix Software said this week that Singapore-based Research Instruments will distribute its line of software products in Singapore, Malaysia and Thailand.

Genomatix said that the partnership has already resulted in a three-year licensing agreement with Singapore General Hospital's Clinical Research Department, which will use the company's microarray analysis software for experiments on the Affymetrix platform.

Klaus May, director of sales and marketing at Genomatix, said in a statement that Research Instruments "is one of the strongest providers of Affymetrix chips and services in this area."


Organon to Deploy Spotfire's DecisionSite Globally

Spotfire said this week that Organon has licensed its DecisionSite software for global deployment across its discovery research organization.

"Spotfire has become an important data-analysis application at Organon," said Jacob de Vlieg, chief information officer for R&D at Organon, in a statement.

The company is using the software in a number of research areas, de Vlieg said, including "chemistry to optimize drug candidates, biology for target and biomarker discovery, and translational medicine."


Bayer HealthCare to Use Genedata´s Expressionist and Phylosopher

Genedata said this week that it has expanded an existing collaboration with Bayer HealthCare to include multiple sites in Germany and the US.

Bayer HealthCare will use the company's Expressionist and Phylosopher software in its target and biomarker research programs. The software will be integrated with Bayer HealthCare's global research informatics infrastructure, Genedata said.


Sanofi-Aventis Expands Terms of Ingenuity License

Ingenuity Systems said this week that it has expanded the terms of its existing agreement with Sanofi-Aventis US for access to Ingenuity's pathway database and Ingenuity Pathways Analysis software.

The agreement began in 2003.

Additional terms of the expanded agreement were not provided.


Molecular Connections to Co-Develop Database with Plasma Proteome Institute

Molecular Connections said this week that it is collaborating with the Plasma Proteome Institute to develop a biomarker-focused plasma protein database by curating the published literature.

Molecular Connections said that its scientists in Bangalore, India, will curate thousands of papers on clinically significant proteins with their protein concentrations in the plasma under pathological conditions.

Additional terms of the agreement were not disclosed.


Eidogen-Sertanty Licenses TIP to NCBI

Eidogen-Sertanty said this week that the National Center for Biotechnology Information has licensed its Target Informatics Platform.

Under the terms of the annual license, scientists at NCBI will have access to the TIP and EVE comparative visualizer.

Financial details were not released.

Filed under

The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.